Global Medical REIT (NYSE:GMRE) Releases FY 2025 Earnings Guidance

Global Medical REIT (NYSE:GMRE) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 4.500-4.600 for the period, compared to the consensus EPS estimate of 4.130. The company issued revenue guidance of -.

Global Medical REIT Price Performance

Shares of NYSE:GMRE traded down $0.12 on Tuesday, hitting $30.34. The stock had a trading volume of 203,357 shares, compared to its average volume of 144,426. Global Medical REIT has a twelve month low of $30.03 and a twelve month high of $47.00. The company has a debt-to-equity ratio of 1.56, a quick ratio of 0.28 and a current ratio of 0.28. The firm’s 50 day moving average price is $34.23 and its 200-day moving average price is $34.30. The company has a market capitalization of $405.98 million, a price-to-earnings ratio of 86.69 and a beta of 1.17.

Global Medical REIT (NYSE:GMRE) last released its quarterly earnings results on Tuesday, November 4th. The company reported $1.12 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.05 by $0.07. Global Medical REIT had a return on equity of 2.21% and a net margin of 7.32%. Global Medical REIT has set its FY 2025 guidance at 4.500-4.600 EPS. On average, equities research analysts predict that Global Medical REIT will post 0.81 earnings per share for the current year.

Global Medical REIT Increases Dividend

The business also recently announced a quarterly dividend, which was paid on Wednesday, October 15th. Stockholders of record on Monday, September 29th were given a dividend of $0.75 per share. This represents a $3.00 annualized dividend and a dividend yield of 9.9%. The ex-dividend date was Monday, September 29th. This is an increase from Global Medical REIT’s previous quarterly dividend of $0.15. Global Medical REIT’s dividend payout ratio is presently 857.14%.

Global Medical REIT declared that its board has initiated a stock buyback program on Wednesday, August 13th that authorizes the company to buyback $50.00 million in shares. This buyback authorization authorizes the company to purchase up to 11.1% of its stock through open market purchases. Stock buyback programs are generally a sign that the company’s management believes its shares are undervalued.

Analyst Ratings Changes

Several brokerages recently issued reports on GMRE. Citigroup upgraded Global Medical REIT to an “outperform” rating in a research report on Monday, October 13th. JMP Securities set a $40.00 price objective on Global Medical REIT and gave the stock a “market outperform” rating in a research note on Monday, October 13th. Weiss Ratings reiterated a “hold (c-)” rating on shares of Global Medical REIT in a research note on Wednesday, October 8th. Wall Street Zen upgraded Global Medical REIT from a “sell” rating to a “hold” rating in a research note on Saturday, October 18th. Finally, Zacks Research upgraded Global Medical REIT from a “hold” rating to a “strong-buy” rating in a research note on Wednesday, September 24th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and three have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $42.50.

Hedge Funds Weigh In On Global Medical REIT

Several large investors have recently bought and sold shares of GMRE. Osaic Holdings Inc. boosted its position in Global Medical REIT by 61.5% in the second quarter. Osaic Holdings Inc. now owns 57,283 shares of the company’s stock worth $401,000 after purchasing an additional 21,810 shares during the last quarter. B. Riley Wealth Advisors Inc. bought a new position in shares of Global Medical REIT during the 2nd quarter valued at about $78,000. State of Wyoming boosted its holdings in Global Medical REIT by 71.3% during the 2nd quarter. State of Wyoming now owns 12,656 shares of the company’s stock valued at $88,000 after acquiring an additional 5,266 shares during the period. CANADA LIFE ASSURANCE Co boosted its holdings in Global Medical REIT by 9.6% during the 2nd quarter. CANADA LIFE ASSURANCE Co now owns 85,740 shares of the company’s stock valued at $595,000 after acquiring an additional 7,500 shares during the period. Finally, Tower Research Capital LLC TRC increased its position in Global Medical REIT by 70.3% during the 2nd quarter. Tower Research Capital LLC TRC now owns 7,379 shares of the company’s stock valued at $51,000 after purchasing an additional 3,046 shares during the period. 57.52% of the stock is currently owned by institutional investors.

About Global Medical REIT

Global Medical REIT Inc (GMRE) is a net-lease medical office real estate investment trust (REIT) that owns and acquires healthcare facilities and leases those facilities to physician groups and regional and national healthcare systems.